Curbside Consults on HIV PrEP

This continuing education activity is provided by

This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Activity Description

Several interventions can be used to increase the use of pre-exposure prophylaxis (PrEP) in geographical regions of the United States with the highest rates of HIV infection. These include conducting targeted outreach to at-risk populations, including men who have sex with men, transgender individuals, and people of color. This could involve partnering with community-based organizations and other local groups to reach those who are most in need. It will also be important to increase education and awareness about the benefits of PrEP and how it works. Another important intervention is to increase access to PrEP through providing PrEP at clinics, hospitals, and pharmacies. In addition, patient–provider communication strategies are needed to increase the rates of patient adherence and follow-up, as well as to mitigate the stigma associated with HIV. Healthcare providers may face racial and health disparities in HIV care and should implement approaches to reduce their occurrence and increase PrEP uptake. Finally, providers need to be aware of and implement current guidelines and best practices for the use of PrEP therapies. Implementing these interventions may help increase the use of PrEP and reduce HIV incidence rates in areas with the highest rates of infection.

To achieve these goals, it is important to ensure interprofessional coordination of HIV patient care for improved outcomes. This would involve working collaboratively with providers, including primary care physicians, specialists, pharmacists, and case managers, to ensure patients receive comprehensive care and support. In this Curbside Consult series, Richard A. Elion, MD, will moderate 4 clinical cases with a panel of experts, highlighting interventions to address disparities, mitigate stigma, and improve adherence, as well as the use of interprofessional coordination for improved outcomes.

Target Audience

The intended audience for this activity is pharmacists and other healthcare professionals involved in the management of patients with or at risk for HIV.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Employ interventions to increase the use of PrEP in geographical regions of the United States with the highest rates of HIV infection.
• Investigate racial and health disparities in HIV care and approaches to reduce their occurrence and increase PrEP uptake.
• Implement current guidelines and best practices for the use of PrEP therapies.
• Utilize interprofessional coordination of HIV patient care for improved outcomes.
• Incorporate patient–provider communication strategies to increase the rates of patient adherence and follow-up as well as to mitigate the stigma associated with HIV.

Activity Chair

Richard A. Elion, MD
Director of Clinical Research
Washington Health Institute
Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC

Faculty

Allison Agwu, MD, ScM, FAAP, FIDSA
Professor of Pediatrics and Internal Medicine
Division of Infectious Diseases
Program Director, Pediatric Adolescent Young Adult HIV/AIDS Program
Medical Director, Accessing Care Early (ACE) Clinic
Project Director, JH-WICY Partnership for Excellence
PI, JHU IMPAACT
Johns Hopkins University School of Medicine
Baltimore, MD

Latesha Elopre, MD, MSPH
Associate Professor
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, AL

Theo W. Hodge Jr, MD
Medical Director
Washington Health Institute
Washington, DC

Raphael J. Landovitz, MD, MSc
Professor of Medicine
Director, UCLA Center for Clinical AIDS Research & Education
University of California, Los Angeles
Los Angeles, CA

Planners/Reviewers

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

This program is acceptable for 1.5 contact hours of ACPE Continuing Education Credit. The ACPE Universal Program Number is JA0006104-0000-23-014-H02-P, effective 5/31/2023. This is a knowledge-based activity, and there is no fee to attend.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the learning objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of 6 of the posttest questions correctly. If a satisfactory score on the posttest is achieved (66%), your statement of participation will be made available immediately. Click on the “View Statement of Participation” link and print the statement for your records. If you receive a score lower than 66%, you will receive a message notifying you that you did not pass the posttest. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded to CPE monitor within 30 days.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s):

Allison Agwu, MD, ScM, FAAP, FIDSA
Advisor: Gilead, ViiV
Consultant: Merck
Independent Research Contractor: Gilead, Merck

Richard A. Elion, MD
Advisor: Gilead, Merck, ViiV
Speaker Contracted by Ineligible Company: Gilead, Merck, ViiV

Latesha Elopre, MD, MSPH
Independent Research Contractor: Merck

Theo W. Hodge Jr., MD
Speaker Contracted by Ineligible Company: Gilead, GSK/ViiV, Janssen

Raphael J. Landovitz, MD, MSc
Advisor: Merck

Planners/Reviewers report the following relevant financial relationship(s):

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Vindico Medical Education Staff:

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

ADA Compliance

In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this web activity is available upon request. Requests should include the web activity title and emailed to CME@VindicoCME.com. Requests will be honored within 3 to 5 business days.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2023 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher.

The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at CME@VindicoCME.com